Cytoprotective agent in Lactobacillus bulgaricus extracts.

Area of Science:

• Microbiology
• Immunology
• Biochemistry

Background:

• Probiotic bacteria like Lactobacillus bulgaricus are known for health benefits.
• Biological activities are often attributed to bacterial cell wall components, such as peptidoglycans.
• The specific active compounds responsible for anti-cytotoxic effects require precise identification.

Purpose of the Study:

• To identify the specific component in Lactobacillus bulgaricus extracts responsible for anti-cytotoxic activity.
• To investigate the role of Adenosine 5 -diphosphoribose (ADP-ribose) in mediating these effects.
• To quantify ADP-ribose levels and assess its inhibitory potential against TNF-alpha mediated cytotoxicity.

Main Methods:

• Extraction and isolation of active compounds from Lactobacillus bulgaricus.
• High-Performance Liquid Chromatography (HPLC) for separation and quantification.
• Nuclear Magnetic Resonance (NMR) spectroscopy for structural identification.
• In vitro cell-based assay to measure inhibition of TNF-alpha mediated cytotoxicity.

Main Results:

• Adenosine 5 -diphosphoribose (ADP-ribose) was identified as a key contributor to the anti-cytotoxic activity.
• ADP-ribose was found to be a hydrolysis product of beta-nicotine adenine dinucleotide (NAD).
• As low as 5 mg/L of ADP-ribose demonstrated significant inhibition of TNF-alpha mediated cytotoxicity.
• L. bulgaricus extracts contained substantial amounts of ADP-ribose, often exceeding 5 mg/g dry weight.

Conclusions:

• ADP-ribose, rather than peptidoglycans, is a primary mediator of the anti-cytotoxic effects observed in L. bulgaricus extracts.
• The findings highlight ADP-ribose as a potent bioactive molecule with potential therapeutic applications in managing cytotoxic damage.
• Further research into ADP-ribose's mechanisms and applications is warranted.